Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Debate Focus Shifts To State Plans: Roth Offers Senate Vehicle

Executive Summary

The final push for a Medicare outpatient drug bill in the 106th Congress will focus on federal funding support for state drug assistance programs.

You may also be interested in...



House State-Based Senior Rx Plan Includes Funds For Pharmacy Services

State governments would be required to allocate a "reasonable percentage" of federal funding for senior drug assistance programs to cover the cost of pharmacy services under Rep. Bilirakis' (R-Fla.) HR 5151.

Medicare Rx State Block Grant Plan Lacks Full Support Of House Republicans

House Republican prescription drug task force members are divided over whether to support a state-based approach to providing prescription drug coverage.

House State-Based Senior Rx Plan Includes Funds For Pharmacy Services

State governments would be required to allocate a "reasonable percentage" of federal funding for senior drug assistance programs to cover the cost of pharmacy services under Rep. Bilirakis' (R-Fla.) HR 5151.

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel